Who is the ceo of korro? Ram Aiyar, Ph.D., MBA, is the chief executive officer of Korro Bio and sits on the board of directors. Ram brings nearly two decades of perse experience in biotech and pharma, working across all stages of development from launch to clinical to commercialization.Why choose korro bio? Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause. Korro Bio’s team of experts is working to overcome the challenges that have limited existing gene editing and gene therapy approaches, and treat diseases that have previously been unreachable by other methods.What is uniquekorro bio? Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients.Who is korro bios david butler? David Butler, Ph.D., vice president of chemistry at Korro Bio, brings over 20 years of oligonucleotide and small molecule chemistry experience in the biotech industry.
Korro Bio is pioneering RNA editing to deliver the future of medicine. Korro Bio’s proprietary platform, OPERA (Oligonucleotide Promoted Editing of RNA), harnesses the body’s natural base editing system — specifically ADAR (Adenosine Deaminase Acting on RNA) — to make precise, single-base edits to RNA.OPERA can repair disease-causing mutations at the RNA level, in ...